Explore more publications!

Press Releases

Insect Protein Market Set to Redefine the Future of Sustainable Nutrition 2026-2034 | DataM Intelligence
Digital Health Market Size to Reach USD 2,351.24 billion by 2034, at CAGR 21.60%
Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight
Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy
Clinical Workflow Solutions Market Size USD 15.99 Bn in 2025 to Reach USD 40.20 Bn by 2034 at 10.92% CAGR (2026-2024)
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDT
Walnut Oil Market Value to Reach US$ 1,307.9 Mn by 2033 Driven by Health Benefits Demand
Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
Hospital HVAC Systems Market Projected to Grow from USD 11.03 Billion in 2024 to USD 22.19 Billion by 2034, with a CAGR of 7.24%
Concentrated Massage Bars Market Set for Accelerated Premium Wellness Expansion, Reaching USD 3.3 Billion by 2036 | FMI
ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL
InnoCare Announces IND Approval to Initiate Clinical Trial of VAV1 Degrader ICP-538 in China
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Fangzhou Wins Tencent Health ‘AI-Powered Future Award’ as MaaS Platform Drives AI Chronic Care
Nut-Based Spreads Market Value Driven by Health Trends and Plant-Based Demand
Agarwood Chips Market to Witness Robust Expansion Driven by Luxury Fragrances and Wellness Demand
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China
Pharmaceuticals Market to Register a Robust CAGR of 8.19% During the 2026–2034 Forecast Period
Medical Exoskeleton Market Size to Reach USD 239.3 Million by 2032 from USD 112.2 Million in 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions